Report copyright - Immunological Pathways in Oncology · PD-1/PD-L1 pathway to reduce effector T-cell function and prevent immune-mediated destruction.7 Conversely, disruption of the PD-1/PD-L1 pathway
Please pass captcha verification before submit form